# sanogenetics.com

> AI-optimized mirror of sanogenetics.com containing 50 pages totalling 62,470 words of clean markdown content, structured data, and semantic HTML. Original source: https://sanogenetics.com/. Last updated: 2026-04-27T02:11:25.101Z.

Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG).

## Homepage

- [One platform for recruitment, genetic testing, and long-term engagement](/site-root.html): Sano’s end-to-end precision medicine platform de-risks trials, enabling clinical operations teams to move 10x faster and reduce cost by 5x.  (1,038 words)

## Articles & Blog Posts

- [resources/blog/crispr-gene-editing-promise-risks-and-regulation/index.html](/resources/blog/crispr-gene-editing-promise-risks-and-regulation/index.html) (1 words)
- [resources/the-genetics-podcast-listing/ep101/index.html](/resources/the-genetics-podcast-listing/ep101/index.html) (1 words)
- [Podcast recap: Michelle Werner and Michael Severino on moving engineered tRNA and gene writing into the clinic](/resources/blog/podcast-recap-michelle-werner-and-michael-severino/index.html): Explore advancements in genetic medicine as Alltrna and Tessera Therapeutics move engineered tRNA and gene writing technologies into human clinical trials. (1,463 words)
- [resources/blog/whats-driving-progress-in-precision-neurology/index.html](/resources/blog/whats-driving-progress-in-precision-neurology/index.html) (1 words)
- [resources/blog/20-clinical-trial-patient-recruitment-companies/index.html](/resources/blog/20-clinical-trial-patient-recruitment-companies/index.html) (1 words)
- [resources/blog/the-principle-of-precision-why-navigating-the-nuances-in-genetic-test-interpretation-is-more-important-than-ever.html](/resources/blog/the-principle-of-precision-why-navigating-the-nuances-in-genetic-test-interpretation-is-more-important-than-ever.html) (1 words)
- [resources/blog/building-the-blueprint-a-strategic-framework-for-precision-medicine-in-autoimmune-and-inflammatory-disease.html](/resources/blog/building-the-blueprint-a-strategic-framework-for-precision-medicine-in-autoimmune-and-inflammatory-disease.html) (1 words)
- [Genomic applications in frontline healthcare for at-risk populations](/resources/blog/genomic-applications-in-frontline-healthcare/index.html): Explore the impact of genomics in frontline healthcare, from newborn screening to personalised treatment journeys, and drug development. (1,342 words)
- [Rethinking drug approval for ultra-rare disease: Inside the UK’s n-of-1 ASO trial](/resources/blog/rethinking-drug-approval-for-ultra-rare-disease-inside-the-uks-n-of-1-aso-trial.html): How the UK’s n-of-1 ASO trial signals a shift toward process-based approvals for ultra-rare diseases and what it could mean for patients. (1,112 words)
- [World Liver Day spotlight: Pioneering genetic solutions for liver disease](/resources/blog/world-liver-day-spotlight/index.html): A curated collection of Sano's liver disease content, shared in honour of World Liver Day. (991 words)
- [AI in genomics: From data analysis to precision care](/resources/blog/ai-in-genomics-from-data-analysis-to-precision-care.html): AI in genomics helps interpret complex genomic data, supporting personalized medicine, prenatal genetic testing, AI drug discovery, and gene therapy research. (1,213 words)
- [AI interpretability challenges](/resources/blog/challenges-and-ethical-considerations-of-ai-in-precision-medicine.html): AI in healthcare can improve insight, but ethical use depends on explainable AI, algorithmic bias control, phenotypic data, consent, privacy, and regulation. (1,264 words)
- [The future of hearing loss treatment](/resources/blog/the-future-of-hearing-loss-treatment/index.html): Discover breakthroughs in gene therapy, pharmacogenomics, and AI driving personalized hearing care, restoring hearing, preventing loss, and enhancing diagnosis. (1,038 words)
- [The promising power and ethical considerations of newborn sequencing (inspired by the World Orphan Drug Congress USA)](/resources/blog/newborn-sequencing/index.html): The Sano team recently attended the World Orphan Drug Congress USA and was fascinated by numerous discussions around newborn genome sequencing. Explore related trends and ethical implications here. 
 (1,314 words)
- [How genomics is influencing treatment of depression and other mental health conditions](/resources/blog/how-genomics-is-influencing-treatment-of-depression-and-other-mental-health-conditions.html): Explore how genomics is reshaping mental health treatment. Learn about genetic links to depression, personalized therapies, and research advancements. (1,098 words)
- [Podcast recap: Anna Lindstrand on implementing short-read and long-read sequencing for rare disease diagnostics](/resources/blog/podcast-recap-anna-lindstrand/index.html): Explore how Sweden's national genomics program enhances rare disease diagnostics through advanced sequencing technologies and coordinated healthcare delivery. (1,352 words)
- [Podcast recap: Wanda Smith on turning a family diagnosis into CureGRN](/resources/blog/podcast-recap-wanda-smith/index.html): Discover Wanda Smith's journey from her mother's misdiagnosis to pioneering progranulin research, shaping future FTD treatments, and advocating for earlier genetic testing. (934 words)
- [Precision medicine in autoimmune & inflammatory care](/resources/blog/how-precision-medicine-is-shaping-the-future-of-autoimmune-and-inflammatory-disease.html): How precision medicine is reshaping autoimmune and inflammatory disease: cell and CAR T therapy, biomarkers, and interoperable data for patient-centered trials. (953 words)
- [Podcast recap: Nicky Whiffin on the discovery of ReNU syndrome and what it unlocks for genetic medicine](/resources/blog/podcast-recap-nicky-whiffin/index.html): Breakthrough in neurodevelopmental disorder linked to non-coding gene RNU4-2 highlights potential for rapid therapeutic development and community-driven research acceleration. (1,382 words)
- [Innovation and regulation in gene and cell therapy](/resources/blog/innovation-and-regulation-in-gene-and-cell-therapy/index.html): Discover the rapid growth in gene and cell therapy trials and the evolving regulatory frameworks accelerating patient access to treatments for rare diseases. (784 words)
- [Webinar recap: Unlocking potential - How AI is shaping the drug development pipeline](/resources/blog/unlocking-potential-how-ai-is-shaping-the-drug-development-pipeline.html): Explore how AI transforms drug development with insights from industry experts in this engaging webinar recap. (1,176 words)
- [Omnichannel recruitment channels for clinical trials](/resources/blog/omnichannel-recruitment-channels-for-clinical-trials.html): Discover the pros and cons of various aspects of an omnichannel approach in clinical trial recruitment. (741 words)
- [Genetic literacy: Prevent drop-off in trial recruitment](/resources/blog/recruitment-mistakes-sponsors-make-around-genetic-literacy-and-how-to-fix-them.html): Genetic literacy is a gating step in precision trials. See where patient recruitment drops before genetic screening and how patient engagement fixes it. (1,454 words)
- [What to consider when using different channels for Parkinson's recruitment](/resources/blog/channels-for-parkinsons-recruitment/index.html): Recruiting patients for Parkinson’s clinical trials is crucial for developing new treatments. Here’s how to effectively use different channels to reach this particular patient population. (988 words)
- [The Genetics Podcast](/resources/the-genetics-podcast-listing/ep1010/index.html): Dr Patrick Short, CEO of Sano, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. (658 words)
- [Areas for patient-centric innovation in cell and gene therapy research](/resources/blog/areas-for-patient-centric-innovation-in-cell-and-gene-therapy-research.html): Discover how patient-centric approaches and clear communication can increase acceptance and success of cell and gene therapies. (1,006 words)
- [The power of natural history studies in rare disease R&D](/resources/blog/the-power-of-natural-history-studies-in-rare-disease-rd.html): Discover how natural history studies accelerate rare disease drug development by providing crucial longitudinal data, improving trial design, and identifying biomarkers for better patient outcomes. (931 words)
- [Podcast recap: The state of AAV gene therapy and where it’s headed](/resources/blog/podcast-recap-the-state-of-aav-gene-therapy-and-where-its-headed.html): Explore the latest advancements and challenges in AAV gene therapy, focusing on safety, scalability, and innovative delivery methods. (1,116 words)
- [How precision patient finding reduces research costs](/resources/blog/how-precision-patient-finding-reduces-research-costs.html): Discover how precision patient finding and comprehensive genome profiling can significantly reduce clinical trial costs. (999 words)
- [Webinar recap: An insider’s view on drug development in MASH with Dimitar Tonev](/resources/blog/webinar-recap-insiders-view-on-drug-development-in-nash.html): In this webinar, Dimitar Tonev, a trained hepatologist and an expert in chronic liver diseases, chatted with Patrick Short, Sano Genetics CEO, to provide insights into the challenges and opportunities in developing drugs for NASH. (844 words)
- [Podcast recap: Daniel Chung on the evolution of retinal gene therapy](/resources/blog/podcast-recap-daniel-chung/index.html): Explore the evolution of retinal gene therapy post-Luxturna, challenges faced, and how Beacon Therapeutics aims to advance treatments for inherited retinal diseases. (871 words)
- [Sano Genetics raises $11M in funding to accelerate genetic disease research](/resources/blog/sano-genetics-raises-11m-in-funding-to-accelerate-genetic-disease-research.html): We are excited to announce our Series A funding round led by MMC Ventures.
 (653 words)
- [How precision medicine is transforming neurological health care](/resources/blog/how-precision-medicine-is-transforming-brain-health-care.html): Explore how precision medicine is transforming neurological care through genetic insights and advanced technologies, overcoming challenges for more personalized treatments and better patient outcomes. (577 words)
- [Webinar recap: The Genetics of MASLD & MASH](/resources/blog/webinar-recap-genetics-nafld-nash/index.html): Webinar recap on the genetics and lifestyle factors that contribute to non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). (743 words)
- [Navigating rare disease patient recruitment](/resources/blog/navigating-rare-disease-patient-recruitment/index.html): This blog shares our latest report, which explores challenges of rare disease patient recruitment and discusses best practices to overcome these hurdles. (338 words)
- [Built for modern trials: How Sano supports advanced genomic therapies](/resources/blog/built-for-modern-trials-how-sano-supports-advanced-genomic-therapies.html): Sano accelerates gene therapy trials by offering patient-centered solutions for recruitment, genetic testing, and retention. (883 words)
- [How Sano Genetics accelerated recruitment for a Parkinson’s disease gene therapy trial](/resources/blog/how-sano-genetics-accelerated-recruitment-for-a-parkinsons-disease-gene-therapy-trial.html): Sano Genetics accelerates recruitment for a Parkinson’s gene therapy trial, showcasing precision outreach and strong participant engagement. (703 words)
- [Electronic medical record retrieval](/services/electronic-medical-record-retrieval/index.html): Save valuable patient screening time by integrating electronic medical records into each patient’s profile. (304 words)
- [Podcast recap: How genomics is rewriting the taxonomy of disease with Dr. Lon Cardon](/resources/blog/podcast-recap-lon-cardon/index.html): Discover how genomics is revolutionizing disease taxonomy and drug discovery through collaboration and data sharing, as discussed by Lon Cardon on The Genetics Podcast. (980 words)
- [Legal landscapes in precision medicine: Market access and intellectual property law [webinar recap]](/resources/blog/legal-landscapes-in-precision-medicine-market-access-and-intellectual-property-law-webinar-recap.html): In this webinar, Sano General Counsel Mina Frost describes the legal complexities of market access and intellectual property in the field of precision medicine. (670 words)
- [Why your clinical trial patient recruitment strategy should include EMR retrieval](/resources/blog/why-your-clinical-trial-patient-recruitment-strategy-should-include-emr-retrieval.html): Explore how and why EMR retrieval can transform your patient recruitment approach.  (697 words)
- [The long haul: How long COVID continues to challenge healthcare](/resources/blog/the-long-haul-how-long-covid-continues-to-challenge-healthcare.html): Our new Insights Report delves deep into the world of long COVID, exploring its impact, treatment options, and genetic components. (307 words)
- [Podcast recap: Harnessing human data in drug development with Jakob Steinfeldt](/resources/blog/podcast-recap-harnessing-human-data-in-drug-development-with-jakob-steinfeldt.html): Explore how Jakob Steinfeldt of Pheiron is transforming drug development through human data. (678 words)
- [Webinar recap: Precision medicine research in Multiple Sclerosis: what is on the horizon?](/resources/blog/webinar-recap-precision-medicine-research-in-ms/index.html): This webinar, hosted by Patrick Short, CEO of Sano Genetics, and featuring Dr. Mark Kotter, CEO of bit.bio, focused on precision medicine in multiple sclerosis. (717 words)
- [Connect with the right patients through data-driven recruitment](/services/recruitment/index.html): With 80% of clinical trials not meeting their enrollment deadlines, finding the perfect participants is more critical than ever. (328 words)
- [Partnering to unlock the next chapter in lupus research](/resources/blog/partnering-to-unlock-the-next-chapter-in-lupus-research.html): Sano Genetics partners with the Lupus Research Alliance to support the launch of the Lupus Nexus Foundational Analyses, accelerating personalized treatments through integrated multi-omic data on the DREAM platform. (485 words)
- [Data security and privacy considerations for the biotech industry](/resources/blog/data-security-and-privacy-considerations-for-the-biotech-industry.html): Explore important data security and privacy considerations for the biotech industry to take into account when selecting vendors and partners. (305 words)
- [The Genetics Podcast](/resources/genetics-podcast/ep105/index.html): Dr Patrick Short, CEO of Sano, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. (25,025 words)
- [sitemap-xml.html](/sitemap-xml.html) (9 words)

## Resources

- [Full Page Index](/index.html): Browse all cached pages with rich metadata
- [About This Cache](/content/about.html): Methodology, technical details, and usage guidelines
- [XML Sitemap](/content/sitemap.xml): Machine-readable sitemap for crawler discovery
- [Robots.txt](/content/robots.txt): Crawler directives